Get the Stockscreener App
19.57
0.41%
0.08
Immunome Inc stock is traded at $19.57, with a volume of 1.42M.
It is up +0.41% in the last 24 hours and up +12.28% over the past month.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
See More
Previous Close:
$19.49
Open:
$19.67
24h Volume:
1.42M
Relative Volume:
0.96
Market Cap:
$1.79B
Revenue:
$12.59M
Net Income/Loss:
$-212.39M
P/E Ratio:
-6.343
EPS:
-3.0853
Net Cash Flow:
$-185.92M
1W Performance:
-0.96%
1M Performance:
+12.28%
6M Performance:
+99.90%
1Y Performance:
+49.73%
1-Day Range:
$18.81
$19.82
1-Week Range:
$18.81
$20.80
52-Week Range:
$5.1501
$20.80
Immunome Inc Stock (IMNM) Company Profile
Name
Immunome Inc
Sector
Industry
Phone
610-321-3700
Address
18702 N. CREEK PARKWAY, BOTHELL
Compare IMNM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMNM
Immunome Inc
|
19.57 | 1.79B | 12.59M | -212.39M | -185.92M | -3.0853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunome Inc Stock (IMNM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | Truist | Buy |
| Sep-22-25 | Initiated | Goldman | Buy |
| Sep-05-25 | Initiated | Craig Hallum | Buy |
| Apr-02-25 | Initiated | Lake Street | Buy |
| Nov-08-24 | Initiated | Stephens | Overweight |
| May-31-24 | Initiated | Piper Sandler | Overweight |
| Apr-30-24 | Initiated | JP Morgan | Overweight |
| Apr-15-24 | Initiated | Guggenheim | Buy |
| Jan-29-24 | Initiated | Leerink Partners | Outperform |
| Dec-19-23 | Initiated | Wedbush | Outperform |
| Oct-29-21 | Initiated | Cantor Fitzgerald | Overweight |
View All
Immunome Inc Stock (IMNM) Latest News
Birchview Capital LP Takes $558,000 Position in Immunome, Inc. $IMNM - MarketBeat
Immunome, Inc. $IMNM Stock Holdings Decreased by Redmile Group LLC - MarketBeat
Natixis Invests $2.13 Million in Immunome, Inc. $IMNM - MarketBeat
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of “Moderate Buy” by Brokerages - Defense World
Immunome (NASDAQ:IMNM) Reaches New 1-Year HighTime to Buy? - MarketBeat
Immunome (NASDAQ:IMNM) Hits New 12-Month HighHere's Why - MarketBeat
Immunome stock hits 52-week high at $20.50 - Investing.com
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Immunome, Inc. (IMNM) -6.5% in After-hours: What’s Driving the Move? - Stocks Telegraph
Can Immunome Inc stock deliver strong Q4 earningsTrade Volume Report & Risk Managed Investment Signals - moha.gov.vn
What drives Immunome Inc stock priceEarnings Surprise Analysis & Make Confident Moves With Forecasting Models - earlytimes.in
Understanding Momentum Shifts in (IMNM) - news.stocktradersdaily.com
Is Immunome Inc (IMNM) positioned for future growth? - setenews.com
Kennedy Capital Management LLC Purchases 94,627 Shares of Immunome, Inc. $IMNM - MarketBeat
Immunome initiated with a Buy at Truist - MSN
Tema Etfs LLC Takes $1.07 Million Position in Immunome, Inc. $IMNM - MarketBeat
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Immunome (NASDAQ:IMNM) Stock Price Up 9.5%Time to Buy? - MarketBeat
Is Immunome Inc a good long term investmentSwing Trading Ideas & Superior Capital Appreciation - earlytimes.in
Immunome (NASDAQ:IMNM) Hits New 1-Year HighShould You Buy? - MarketBeat
Immunome (NASDAQ:IMNM) Trading Down 6.7%Here's Why - MarketBeat
Immunome stock hits 52-week high at 19.16 USD By Investing.com - Investing.com Australia
Immunome stock hits 52-week high at 19.16 USD - Investing.com
It makes sense and dollars to buy Immunome Inc (IMNM) stock - setenews.com
Truist Financial Initiates Coverage on Immunome (NASDAQ:IMNM) - MarketBeat
Immunome (NASDAQ:IMNM) Coverage Initiated by Analysts at Truist Financial - Defense World
Immunome (IMNM) Stock Analysis Report | Financials & Insights - Benzinga
Truist Securities initiates coverage on Immunome stock with Buy rating By Investing.com - Investing.com South Africa
IMNM: Truist Securities Initiates Coverage with 'Buy' Rating and - GuruFocus
Truist Securities initiates coverage on Immunome stock with Buy rating - Investing.com India
Truist Initiates Immunome at Buy With $36 Price Target - marketscreener.com
Intech Investment Management LLC Buys 6,141 Shares of Immunome, Inc. $IMNM - Defense World
Geode Capital Management LLC Has $17.31 Million Stock Holdings in Immunome, Inc. $IMNM - MarketBeat
Avoiding Lag: Real-Time Signals in (IMNM) Movement - news.stocktradersdaily.com
How institutional buying supports Immunome Inc. stock2025 Trading Recap & Real-Time Stock Entry Alerts - moha.gov.vn
Immunome Inc Stock Analysis and ForecastSell Signals and Alerts & Free Proven Portfolio Growth Strategies - earlytimes.in
Immunome to Present at Upcoming December 2025 Investor Conferences - BioSpace
Immunome (NASDAQ:IMNM) Sets New 12-Month HighHere's Why - MarketBeat
Immunome Inc (IMNM) is looking forward to a strong quarter - Setenews
Immunome to Present at Upcoming Investor Conferences - marketscreener.com
Immunome price target raised to $33 from $25 at Stephens - MSN
Immunome (NASDAQ:IMNM) Upgraded at Wall Street Zen - Defense World
Immunome, Inc. $IMNM Shares Sold by Primecap Management Co. CA - MarketBeat
Immunome, Inc.Common Stock (NQ: IMNM - Markets Financial Content
Immunome stock hits 52-week high at $18.79 By Investing.com - Investing.com Nigeria
Immunome stock hits 52-week high at $18.79 - Investing.com
Will Immunome Inc. stock attract more institutional investorsEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What technical signals suggest for Immunome Inc. stockEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
How Immunome Inc. stock benefits from tech adoptionTrade Analysis Summary & Short-Term Trading Alerts - newser.com
Will Immunome Inc. stock outperform value stocks2025 Geopolitical Influence & Weekly Top Performers Watchlists - newser.com
Is Immunome Inc. stock a safe haven assetGDP Growth & Weekly Top Gainers Trade List - newser.com
Immunome Inc Stock (IMNM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):